Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-01-03 @ 12:28 PM
Study NCT ID:
NCT03447769
Status:
TERMINATED
Last Update Posted:
2024-10-09
First Post:
2018-02-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A
Sponsor:
Organization: